PERFORMANCE BY THE NUMBERS: 2026 STATUS
98 % Reduction Target( by 2026) – AstraZeneca is targeting a 98 % absolute reduction in Scope 1 and 2 emissions by 2026, against a 2015 baseline, with residual emissions addressed through carbon removals.
77.5 % Achieved( as at end-2024 reporting) – The company reports a 77.5 % absolute reduction in operational( Scope 1 and 2) greenhouse gas emissions vs. 2015, demonstrating substantial progress toward its 2026 goal.
~ 20 % Energy Reduction( vs. 2015) – AstraZeneca reports a c. 20 % absolute reduction in total site energy consumption compared with 2015, exceeding its original 10 % reduction target.. 95 % Supplier Spend Target( by end- 2025) – By 2025, AstraZeneca aims for 95 % of purchased goods, services and capital goods spend to be with suppliers that have science-based targets aligned to 1.5 ° C pathways.
100 % Renewable Electricity( by end-2025) – The company has committed to sourcing 100 % renewable electricity across global operations by 2025.
This isn’ t merely about ticking boxes for compliance, it’ s a strategic co-investment in supplier capabilities that effectively raises the standard for the entire category The company has publicly committed investment to support the transition, signalling that sustainability is mission-critical rather than optional.
That supplier focus is already measurable. AstraZeneca reports strong progress on sustainable packaging and fleet electrification, and its supplier disclosure efforts
110 April 2026